CAR-T cell therapy is an immunotherapy used to treat certain types of blood cancer. Researchers genetically modify a patient’s own immune cells, called T cells. The modified “CAR-T” cells are infused back into the patient to help locate and destroy the cancer cells. Many therapy manufacturers create a second dose or backup of the patient’s CAR-T cells for safekeeping in long-term storage. In a NEW case study, we explore: • CAR-T therapy development and sample storage challenges • SciSafe’s second dose CAR-T storage protocols and best practices • Benefits + results of working with an experienced biostorage partner for second dose CAR-T sample storage ✅ Check out our NEW CAR-T storage web page and make sure to download the case study. #outsourcedstorage #CART #celltherapystorage #chimericantigenreceptor #tcell
SciSafe Inc.’s Post
More Relevant Posts
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Illumina board agrees to spin off Grail rather than sell the cancer diagnostics firm >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharma #productmarketing #pharmaceutical
Illumina board agrees to spin off Grail rather than sell the cancer diagnostics firm
https://endpts.com
-
Thoughts on this? >> Lilly's Retevmo lands new accelerated approval for pediatric cancers >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #healthcare #productmarketing
Lilly's Retevmo lands new accelerated approval for pediatric cancers
https://endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Lilly's Retevmo lands new accelerated approval for pediatric cancers >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #healthcare #pharma #productmarketing
Lilly's Retevmo lands new accelerated approval for pediatric cancers
https://endpts.com
-
Thoughts on this? >> Is TGF-β making a comeback in cell therapy? >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #competitivemarketing #pharma #healthcare
Is TGF-β making a comeback in cell therapy? | Biotech Strategy Blog
https://biotechstrategyblog.com
-
A well-known chemotherapy drug called #Olaparib shrinks tumors by killing cancer cells. However, #cancer cells in the body are surrounded by a host of other cell types, all dedicated to promoting tumor growth and thwarting threats from anti-cancer therapies. These outer cells can significantly impede the success of Olaparib. On top of this, chemotherapy’s notorious side effects are partly caused by the indiscriminate killing of healthy cells. The advent of the #CRISPR/Cas9 system for gene editing has heralded an alternative strategy for tumor targeting — one that aims to personalize cancer #therapy and minimize off-target effects. Enquire for Olaparib at sales@avanscure.com or visit https://lnkd.in/dk86zVkp Read more about it here https://lnkd.in/damG9bK9
Olaparib | CAS Number : 763113-22-0 | Avanscure
avanscure.com
-
Thoughts on this? >> Novel strategies for taking on advanced cancers >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #competitivemarketing #pharma #biotech
Novel strategies for taking on advanced cancers | Biotech Strategy Blog
https://biotechstrategyblog.com
-
Business Development & Director Clinical Operations at Indivumed Therapeutics
Last day of #BIOEuropeSpring by EBD Group in Barcelona, but not last chance to engage with peers in drug discovery and pharmaceuticals. At Indivumed Therapeutics we strive to bring novel therapies to treat #cancer patients. Collaborations and partnerships are crucial to advance together to bring #targetdiscovery programs to the clinical stage. Stay tuned! #clinicalresearch #beyondgenomics #proteomics #phosphoproteomics #data #multiomics #mathematics #bioinformatics
-
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Genentech, Blueprint tout full approval for Gavreto in rare type of lung cancer >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #pharmaceutical #biotech #productmarketing
Genentech, Blueprint tout full approval for Gavreto in rare type of lung cancer
https://endpts.com
-
Thoughts on this? >> Adaptimmune taps Galapagos to decentralize manufacturing of solid tumor T cell therapy >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #pharma #healthcare #biotech
Adaptimmune taps Galapagos to decentralize manufacturing of solid tumor T cell therapy
https://endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
NightHawk becomes pure-play CDMO; Lonza to make liver cancer drug; BioNTech gears up to open first site in Africa >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #pharmaceutical #biotech #productmarketing
NightHawk becomes pure-play CDMO; Lonza to make liver cancer drug; BioNTech gears up to open first site in Africa
https://endpts.com
Dan Storey - Thank you for your nice comment and support!